Testing a hospital program for high blood pressure in inpatients
Tests a hospital unit program for managing high blood pressure in adults admitted.
Key facts
- Who runs it
- Elizabeth Pfoh
- Where
- Cleveland and Mayfield Heights, United StatesSee the 2 sites
- Trial code
- Registry title
- Evaluating Whether Treating Elevated Blood Pressure in the Inpatient Setting Impacts Patient Outcomes
- Status
- Recruiting
- People taking part
- 4 people, planned
- Started
- 11 Nov 2025
- Expected to end
- 31 Jul 2027
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- ACT-BP Intervention
- Record updated
- 8 January 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial looks at hospital medical units, not individual volunteers. It tests a unit-based approach to managing high blood pressure in patients admitted to hospital.
- Age
- 18 years and older.
- Sex
- All sexes can join.
- Disease stage
- Patients on medical units that do not usually give step-down care. Their systolic blood pressure must reach 160 mmHg or higher during the hospital stay.
Main reasons for not taking part
- Under 18
- Hypertensive emergency, cardiac symptoms or active cardiovascular events (such as stroke or myocardial infarction)
- End-stage renal disease, dialysis or acute decompensated heart failure
- On the unit for more than 10 days, transferred in from the intensive care unit, or discharged within 24 hours of admission
- Pregnant and post-partum women
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- At the unit level: Medical units that do not typically care for patients requiring step-down care
Who cannot take part
- Patients experiencing hypertensive emergencies or cardiac symptoms
- Patients with active cardiovascular events, such as; Stroke; Non-ST-elevation; Myocardial infarction; End-stage renal disease; Patients on dialysis; Those with acute decompensated heart failure
- Patients less than 18
- Patients on the unit for more than 10 days
- Patients transferred in after being in the intensive care unit (ICU)
- Pregnant and post-partum women
- Patients discharged within 24 hours of admission
- Patients whose systolic BP remains below 160 mmHg during hospitalization
Where in United States
- Cleveland Clinic - Main CampusCleveland, United StatesContact: Emma J WensinkTaking people
- Cleveland Clinic HillcrestMayfield Heights, United StatesContact: Emma J WensinkTaking people
About the trial
What the trial wants to find out
The vast majority of the 36.2 million individuals admitted to U.S. hospitals are diagnosed with hypertension and experience an elevated blood pressure (BP) reading during hospitalization. There are no guidelines for managing asymptomatically elevated BPs in the inpatient setting, and growing observational evidence suggests that antihypertensive medication intensification increases harm. The proposed study tests whether a unit-based intervention (ACT-BP) can reduce antihypertensive medication intensification and provides information that is scientifically necessary for designing a cluster-randomized clinical trial that identifies the impact of intensification after experiencing an asymptomatically elevated BP on patient outcomes.
The 2 groups in the trial
- Intervention ArmTreatment being tested
The ACT-BP protocol will be implemented in the intervention units. First, the study team will implement an order on the unit that prompts the nurses to follow the ACT-BP algorithm when a patient has an asymptomatic elevated BP between 160mmHg and 199mmHg. This protocol does not apply to patients who are experiencing hypertensive emergencies or cardiac symptoms. To increase adherence to the ACT-BP protocol, knowledge related to treating the potential underlying causes of an asymptomatically elevated BP and the current state of the evidence will be shared through posters, information sheets and knowledge sessions. At the the intervention hospital, the study team will provide caregivers (including physicians) with knowledge related to the state of the evidence for treating asymptomatically elevated BPs through emails, information sheets and one-pagers.
Treatment: ACT-BP Intervention
- Control ArmNo study treatment, for comparison
In the control units, care will continue as usual. At the the control hospital, caregivers (including physicians) will receive knowledge related to the state of the evidence for treating asymptomatically elevated BPs through an email.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Evaluating Whether Treating Elevated Blood Pressure in the Inpatient Setting Impacts Patient Outcomes: the ACT-BP Pilot
- Plain-language title
- Testing a hospital program for high blood pressure in inpatientsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 8 January 2026